Metaiodobenzylguanidine (mIBG) molecular imaging in implantable cardioverter defibrillator (ICD) therapy planning: a health technology assessment issue.
Lucignani
Giovanni
G
Department of Biomedical Sciences and Technologies and Centre of Molecular and Cellular Imaging (IMAGO), University of Milan, Milan, Italy. giovanni.lucignani@unimi.it
D019797:3-Iodobenzylguanidine; D020811:Biomedical Technology / Q000191:economics / Q000379:methods* / Q000639:trends; D017147:Defibrillators, Implantable / Q000009:adverse effects / Q000191:economics / Q000639:trends; D006801:Humans
D019797:3-Iodobenzylguanidine